NxStage Medical, Inc. (NASDAQ:NXTM)

CAPS Rating: 2 out of 5

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure.


Player Avatar stocklade (33.58) Submitted: 1/25/2013 11:59:19 PM : Outperform Start Price: $11.75 NXTM Score: -18.73

Great way of treating renal diseases, Can 't understand why they haven 't Done better. ? Doctor owned dialysis centers

Featured Broker Partners